Literature DB >> 15655245

Hepatoma-derived growth factor. Significance of amino acid residues 81-100 in cell surface interaction and proliferative activity.

Mekky M Abouzied1, Heba Mahmoud El-Tahir, Lars Prenner, Hanns Häberlein, Volkmar Gieselmann, Sebastian Franken.   

Abstract

Hepatoma-derived growth factor (HDGF) has proliferative, angiogenic, and neurotrophic activity. It plays a putative role in the development and progression of cancer. When expressed in cells, the mitogenic activity of HDGF depends on its nuclear localization, but it also stimulates proliferation when added to the cell culture medium. A cell surface receptor for HDGF has not been identified so far. We investigated the interaction of various purified recombinant HDGF fusion proteins with the cell surface of NIH 3T3 fibroblasts. We showed that binding of a HDGF-beta-galactosidase fusion protein to the cell surface of NIH 3T3 fibroblasts was saturable, occurred with high affinity (K(D) = 14 nm), and had a proliferative effect. We identified a peptide comprising amino acid residues 81-100 within the amino-terminal part of HDGF that bound to the cell surface of NIH 3T3 cells with saturation and affinity values similar to those of HDGF. When added to primary human fibroblasts, this peptide stimulated proliferation. Substitution of a single amino acid (K96A) within this peptide was sufficient to abolish its binding to the cell surface and its proliferative activity. In contrast, when expressed transiently in NIH 3T3 cells, a HDGF-beta-galactosidase fusion protein in which amino acid residues 81-100 were deleted still had proliferative activity, whereas a fusion protein containing only the 81-100 peptide did not. Our results suggest the existence of a plasma membrane-located HDGF receptor for which signaling depends on amino acid residues 81-100 of HDGF. This region differs from the one that has been recently identified to be essential for mitogenic activity depending on the nuclear localization of HDGF. Thus, HDGF exerts its proliferative activity via two different pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15655245     DOI: 10.1074/jbc.M414652200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.

Authors:  Sen Guo; Hong-da Liu; Yan-Feng Liu; Lei Liu; Qiang Sun; Xi-Jun Cui
Journal:  Tumour Biol       Date:  2014-09-28

2.  Proteomic analysis of the hyaloid vascular system regression during ocular development.

Authors:  Elena Albè; Jin-Hong Chang; Nathalie F Azar; Alexander R Ivanov; Dimitri T Azar
Journal:  J Proteome Res       Date:  2008-10-08       Impact factor: 4.466

3.  Antibodies targeting hepatoma-derived growth factor as a novel strategy in treating lung cancer.

Authors:  Hening Ren; Zuoming Chu; Li Mao
Journal:  Mol Cancer Ther       Date:  2009-05-12       Impact factor: 6.261

4.  Anti-HDGF targets cancer and cancer stromal stem cells resistant to chemotherapy.

Authors:  Jun Zhao; Mark Z Ma; Hening Ren; Zhenqiu Liu; Martin J Edelman; Hong Pan; Li Mao
Journal:  Clin Cancer Res       Date:  2013-05-21       Impact factor: 12.531

5.  Overexpression of hepatoma-derived growth factor in melanocytes does not lead to oncogenic transformation.

Authors:  Angela Sedlmaier; Nicolas Wernert; Rainer Gallitzendörfer; Mekky M Abouzied; Volkmar Gieselmann; Sebastian Franken
Journal:  BMC Cancer       Date:  2011-10-20       Impact factor: 4.430

6.  Expression of hepatoma-derived growth factor family members in the adult central nervous system.

Authors:  Heba M El-Tahir; Frank Dietz; Ralf Dringen; Kerstin Schwabe; Karen Strenge; Sørge Kelm; Mekky M Abouzied; Volkmar Gieselmann; Sebastian Franken
Journal:  BMC Neurosci       Date:  2006-01-23       Impact factor: 3.288

7.  Hepatoma-derived growth factor-related protein-3 is a novel angiogenic factor.

Authors:  Michelle E LeBlanc; Weiwen Wang; Nora B Caberoy; Xiuping Chen; Feiye Guo; Gabriela Alvarado; Chen Shen; Feng Wang; Hui Wang; Rui Chen; Zhao-Jun Liu; Keith Webster; Wei Li
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

Review 8.  Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma.

Authors:  Hirayuki Enomoto; Hideji Nakamura; Weidong Liu; Shuhei Nishiguchi
Journal:  Int J Mol Sci       Date:  2015-06-19       Impact factor: 5.923

9.  Hepatoma-derived Growth Factor Predicts Disease Severity and Survival in Pulmonary Arterial Hypertension.

Authors:  Jun Yang; Melanie K Nies; Zongming Fu; Rachel Damico; Frederick K Korley; Paul M Hassoun; David D Ivy; Eric D Austin; Allen D Everett
Journal:  Am J Respir Crit Care Med       Date:  2016-11-15       Impact factor: 21.405

10.  Hepatoma-derived growth factor and nucleolin exist in the same ribonucleoprotein complex.

Authors:  Stephanie Bremer; Katharina Klein; Angela Sedlmaier; Mekky Abouzied; Volkmar Gieselmann; Sebastian Franken
Journal:  BMC Biochem       Date:  2013-01-10       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.